Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years ...Middle East

- 94% of patients (51 of 54) remained free from the burden of continuous prophylaxis treatment through five years following a single infusion of HEMGENIX, demonstrating sustained therapeutic benefit - At year five, mean factor IX activity levels remained strong at 36.1% and HEMGENIX...

Hence then, the article about data published in the new england journal of medicine confirm the long term durability and safety of hemgenix etranacogene dezaparvovec drlb over five years was published today ( Sunday 07/12/2025 - 08:14 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years )

Also on site :

• Coach of softball teams in San Bernardino, Orange counties accused of molesting player
• The Biggest Fitness Trends at CES 2026 (and What I Think About Them)
• Route 59 in Naperville closed after Tesla crashes, bursts into flames